Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

• The importance of rare earth elements has grown significantly alongside the global energy transition.
• Canamera Energy Metals is accelerating exploration activities at its Turvolândia rare earth project in Minas Gerais, Brazil. 
• The company also filed an independent NI 43-101 technical report for its Jaguaribe rare earth project in Ceará State, Brazil.

Rare earth elements are becoming increasingly essential to the modern global economy, powering technologies that range from electric vehicles and renewable energy systems to advanced defense applications and consumer electronics. As governments and industries push to secure stable supplies of these critical materials outside of dominant supply regions, companies advancing new rare earth projects are drawing heightened attention. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) is positioning itself within that growing strategic landscape through continued progress at its Brazilian rare earth projects, highlighted by recent announcements involving accelerated exploration activities and the filing of an independent technical report.

The importance of rare earth elements has grown significantly alongside the global energy transition. According to the International Energy Agency, critical minerals such as rare earths are essential for technologies tied to electrification, clean energy and advanced manufacturing, with demand expected to rise substantially over the coming decades. Rare earth magnets are used extensively in electric motors, wind turbines and precision electronic systems because of their strength and efficiency.

At the same time, supply-chain concentration remains a major concern. China continues to dominate global rare earth mining and processing capacity, leading western governments and industries to prioritize the development of alternative supply sources. Analysis from the Center for Strategic and International Studies notes that China controls roughly 70% of rare earth mining and approximately 90% of processing capacity, underscoring the strategic importance of projects located in other jurisdictions. This backdrop has increased interest in countries such as Brazil, which hosts significant rare earth potential but remains comparatively underexplored.

Canamera’s recent announcements indicate the company is continuing to move aggressively to expand and define its rare earth assets in Brazil and strengthen its position in the REE space. The company is accelerating exploration activities at its Turvolândia rare earth project in Minas Gerais, Brazil. The company stated that the expanded program is designed to further evaluate ionic clay-hosted rare earth mineralization across the property.

Ionic clay deposits are especially significant within the rare earth industry because they can often be processed using relatively simpler and lower-cost extraction methods compared with hard rock rare earth deposits. Brazil has increasingly attracted attention for this type of mineralization because some of its geological formations resemble the ionic clay systems historically developed in southern China.

Canamera’s announcement noted that the accelerated exploration program follows encouraging early drilling and sampling results at Turvolândia. The company stated that it plans to increase auger drilling density, expand target areas and continue metallurgical and geological evaluation work. This type of systematic exploration approach is important because it allows the company to better define the scale, continuity and characteristics of the mineralized zones.

Canamera also filed an independent NI 43-101 technical report for its Jaguaribe rare earth project in Ceará State, Brazil. Technical reports prepared under NI 43-101 standards are significant milestones for mineral exploration companies because they provide independently reviewed geological and technical information intended to meet regulatory disclosure standards.

According to the company, the report supports the geological prospectivity of the Jaguaribe property and provides additional technical context regarding the project’s rare earth mineralization potential. Independent reports can help strengthen the credibility of exploration programs by providing outside verification and analysis of project data.

Together, these two developments suggest Canamera is advancing along multiple fronts simultaneously. The company is not only continuing active field exploration at Turvolândia but also formalizing technical documentation and disclosure around Jaguaribe. This combination of ongoing exploration and technical advancement reflects a broader effort to build a diversified rare earth portfolio in Brazil.

The company’s strategy appears aligned with growing geopolitical and industrial trends favoring diversified rare earth supply chains. As demand for magnet rare earth elements increases, governments and manufacturers are seeking supply relationships that reduce dependence on highly concentrated processing regions. Projects located in jurisdictions with supportive geology and mining potential may therefore become increasingly important to global supply diversification efforts.

Canamera’s focus on ionic clay-hosted rare earth mineralization may also prove strategically important. Ionic clay systems are viewed favorably because of their potential for simpler extraction processes and lower-cost development compared with more complex hard rock projects. Successful development of these types of deposits outside China could help broaden global rare earth supply options.

The company’s recent announcements also indicate that management is working to advance projects through multiple stages of evaluation and development rather than relying solely on conceptual exploration. Accelerating field programs, increasing drilling activity and filing independent technical reports are all steps commonly associated with building project credibility and preparing for longer-term advancement.

As the rare earth sector continues evolving, companies capable of demonstrating both geological potential and systematic project advancement are likely to attract increasing attention from investors and industry participants. Canamera Energy Metals’ recent progress in Brazil reflects this broader trend, positioning the company within a rapidly growing segment of the critical minerals industry.

With rare earth demand continuing to expand alongside electrification, renewable energy deployment and advanced technology manufacturing, the strategic value of new rare earth projects may continue rising. Through its exploration efforts at Turvolândia and its advancing technical work at Jaguaribe, Canamera Energy Metals is working to establish itself as part of the next generation of non-Chinese rare earth development companies.

For more information, visit the company’s website at CanameraMetals.com. 

NOTE TO INVESTORS: The latest news and updates relating to EMETF are available in the company’s newsroom at ibn.fm/EMETF

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This document contains “forward-looking information” within the meaning of applicable securities legislation, including statements regarding: the Company’s planned exploration activities on its projects; the anticipated timing and completion of the earn-in milestones under the Option Agreement; the Company’s ability to make required cash and share payments and incur required exploration expenditures; the geological prospectivity of its projects; and the Company’s exploration strategy.

Forward-looking information is based on assumptions, estimates, and opinions of management at the date the statements are made and is subject to a variety of risks and uncertainties that could cause actual results to differ materially from those anticipated or projected. These assumptions include, without limitation: the Company’s ability to raise sufficient capital to fund its exploration programs and option payments; favourable regulatory conditions; continued access to its projects; and general economic conditions.

Important risk factors that could cause actual results to differ materially include, but are not limited to: uncertainties related to raising sufficient financing; the inherently speculative nature of mineral exploration; title risks; environmental and permitting risks; and fluctuations in uranium prices. Additional risk factors affecting the Company can be found in the Company’s continuous disclosure documents available at www.sedarplus.ca.

Readers are cautioned not to place undue reliance on forward-looking information.

• Earth Science Tech has evolved into a diversified healthcare holding company with operations spanning telemedicine, compounding pharmacies, clinical support services and healthcare fulfillment.
• In addition, the company has actively reduced its share count through a series of share repurchases documented in SEC filings and share structure records.
• Earth Science Tech repurchased 3.7 million shares over the nine months ended December 31, 2025, spending approximately $647,000.
• Management continues to emphasize shareholder value through balance-sheet management alongside acquisitions and operating growth.
• The company is scheduled to present to investors at the Planet MicroCap Las Vegas 2026 conference in June.

For many investors evaluating companies on the OTC market, share structure often receives as much attention as revenue growth or acquisition activity. Earth Science Tech (OTC: ETST), a strategic holding company spanning telemedicine, pharmacies, clinical support services, and healthcare fulfillment, has increasingly distinguished itself in share structure and financial stability through a sustained program of share repurchases, which has reduced outstanding shares while the company simultaneously expands its healthcare-focused operating platform.

The company’s most recent Form 10-Q, covering the quarter ended December 31, 2025, provides a detailed look at the pace of those repurchases (https://ibn.fm/Gm12j). According to the filing, Earth Science Tech repurchased 1,143,000 common shares during the quarter for approximately $177,659 through private transactions with shareholders. The purchases included 380,000 shares acquired on October 28, 2025, at $0.08 per share and an additional 763,000 shares purchased on December 10, 2025, at $0.193 per share.

The buyback activity extends well beyond a single quarter. For the nine months ended December 31, 2025, the company reported repurchasing 3,703,296 shares for a total cost of approximately $647,087. Those transactions included purchases of 1,050,296 shares in April 2025, 1,510,000 shares in September 2025, 380,000 shares in October 2025 and 763,000 shares in December 2025.

The significance of those repurchases becomes more apparent when compared with the company’s current share structure. Earth Science Tech reported 290.6 million shares outstanding as of June 1, 2026. The same data shows a reduction of approximately 715,000 shares during the most recent three-month period, a decline of 1.8 million shares over six months and a decrease of approximately 3.69 million shares over the last twelve months. Those figures closely mirror the repurchase activity disclosed in SEC filings (https://ibn.fm/cxJkG). 

The historical share structure data also provides a timeline of share reductions. Outstanding shares declined from more than 294.3 million in September 2025 to approximately 290.6 million by June 2026, reflecting a series of cancellations and repurchases over that period.

For investors accustomed to seeing microcap companies expand share counts through repeated equity issuance, Earth Science Tech’s approach stands out. The company maintains 300 million authorized shares, leaving relatively limited separation between authorized and outstanding stock. As of June 2026, approximately 215.1 million shares were classified as restricted, while the public float stood at roughly 40.8 million shares.

While share repurchases alone do not determine investment performance, they can provide insight into management’s capital allocation priorities. In ETST’s case, the reduction in outstanding shares suggests an emphasis on preserving shareholder ownership percentages while executing a broader corporate growth strategy.

The company’s growth strategy has successfully evolved over the past several years, transitioning away from its legacy wellness operations and repositioning itself as a diversified holding company focused primarily on healthcare-related businesses. The company now operates through subsidiaries involved in pharmaceutical compounding, telemedicine, clinical support services, healthcare fulfillment, real estate investments and cash management activities.

The central theme behind the model is vertical integration. Management has assembled businesses that participate in multiple stages of the patient-care process, from initial consultation and telehealth interactions to prescription fulfillment and ongoing support services. Telemedicine platforms serve as a front-end entry point for patients seeking medical consultations and treatment options. Compounding pharmacies then provide customized prescription fulfillment, creating recurring interactions that can extend over long periods.

By integrating these functions internally, the company seeks to capture value across multiple stages of the healthcare continuum rather than relying on a single revenue stream. The structure offers exposure to sectors that continue to benefit from long-term healthcare demand trends, including personalized medicine, telehealth adoption and outpatient care delivery.

At the same time, management has continued emphasizing financial discipline. The share repurchase program demonstrates a willingness to deploy capital toward reducing share count while pursuing operating expansion. That balance between acquisition-driven growth and shareholder-focused capital management has become a recurring theme in company communications.

Regarding investor visibility, the company announced that Chairman and Chief Executive Officer Giorgio R. Saumat will present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17 at the Bellagio Resort & Hotel. The event, organized in conjunction with MicroCapClub, brings together microcap companies and investors for presentations and one-on-one meetings. The conference appearance offers management an opportunity to discuss the company’s operating strategy, healthcare platform and capital allocation priorities directly with investors.

For shareholders, however, one of the clearest signals may already be visible in the numbers. While many small-cap and OTC companies face scrutiny over expanding share counts, Earth Science Tech’s recent filings and share structure records show a different pattern. More than 3.7 million shares were repurchased during the nine months ended December 2025, and the company’s outstanding share count has continued trending lower into 2026.

For more information, visit the company’s website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST 

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.

• The growing burden of neurological disease has intensified industry-wide interest in therapies capable of protecting neurons, preserving brain function and addressing disease progression at a biological level.
• Quantum BioPharma’s flagship pharmaceutical subsidiary, Lucid Psycheceuticals Inc., is advancing LUCID-MS, a patented new chemical entity being developed for an unmet need in multiple sclerosis.
• The company has also expanded its presence in a consumer ready product in the field of alcohol health and sobriety through its involvement with unbuzzd(TM), an innovative, clinically validated alcohol metabolism accelerator designed to help sober people up faster.

Neurological disorders are increasingly recognized as one of the world’s most significant healthcare challenges as aging populations and rising disease prevalence place growing pressure on healthcare systems globally. According to the World Health Organization, neurological conditions are now the leading cause of illness and disability worldwide, affecting more than one-third of the global population. Despite advances in treatment, many currently approved therapies for neurodegenerative diseases primarily focus on symptom management rather than directly addressing underlying neurodegeneration, leaving substantial unmet medical needs across the sector.  Current drugs for multiple sclerosis do not address loss of mobility and function which remains an unmet patient need today.

Against this backdrop, Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), is advancing a novel, new chemical entity patented approach to multiple sclerosis.. 

The growing burden of neurological disease has intensified industry-wide interest in therapies capable of protecting neurons, preserving brain function and addressing disease progression at a biological level. Research that neurological disorders represent the leading cause of disability-adjusted life years globally, underscoring the expanding societal and economic impact of diseases such as Multiple Sclerosis, Alzheimer’s disease and Parkinson’s disease. In the United States alone, neurological disorders generate billions of dollars annually in healthcare costs, lost productivity and long-term care expenses. Researchers and biotechnology companies are increasingly pursuing therapies designed not only to treat symptoms but also to target the mechanisms responsible for neuronal injury and degeneration.

Quantum BioPharma operates as a biopharmaceutical company focused on developing treatments and biotech solutions targeting neurodegenerative, metabolic and alcohol misuse disorders. The company’s business strategy combines clinical-stage therapeutic development with additional biotech and strategic investment initiatives designed to diversify potential value creation opportunities. The company’s lead focus is neurological disease and the advancement of therapies that could potentially address major unmet needs worldwide.

Quantum BioPharma’s flagship pharmaceutical subsidiary, Lucid Psycheceuticals Inc., is advancing LUCID-MS, a patented new chemical entity being developed for multiple sclerosis. Unlike many currently approved MS therapies that primarily target immune system modulation, Lucid-MS is designed as a neuroprotective therapy focused on preventing myelin degradation, a key driver of neurological damage in multiple sclerosis. 

Quantum BioPharma has reported that preclinical animal model studies demonstrated the compound’s ability to prevent and reverse myelin degradation in disease models. One company-produced video reports on a mouse regaining its ability to walk after treatment witih LUCID-MS.  

While Lucid-MS represents the company’s lead pharmaceutical program, Quantum BioPharma has also expanded its presence into metabolic and alcohol misuse-related wellness technologies through its involvement with unbuzzd(TM), an innovative, clinically validated alcohol metabolism accelerator designed to help sober people up faster. The company developed the original unbuzzd intellectual property and later spun out the over-the-counter version to Unbuzzd Wellness Inc., while retaining a significant ownership position and royalty rights tied to future sales. 

According to Quantum BioPharma, unbuzzd was developed by a research and development team specializing in pharmacology and medicine and is intended to help accelerate alcohol metabolism, restore mental alertness and reduce symptoms associated with alcohol consumption. The product contains a proprietary blend of vitamins, minerals and supplements designed to support liver and brain function after drinking. The company positions the product not simply as a hangover remedy but as part of a broader effort to address societal burdens associated with alcohol misuse and intoxication. 

The company has highlighted growing scientific validation surrounding unbuzzd in a first of its kind clinical study. In March 2026, Quantum BioPharma announced the publication of a peer-reviewed, double-blind, randomized, placebo-controlled crossover clinical study evaluating unbuzzd. According to the published findings, participants receiving unbuzzd experienced reductions in blood alcohol concentration more than 40% faster within the first 30 minutes compared with placebo. The study also reported improvements in alertness, reduced mental fatigue and reductions in hangover symptoms without reported adverse side effects. 

Quantum BioPharma maintains financial participation in the commercialization of unbuzzd through both equity ownership and royalty agreements. The company disclosed that it retains approximately 20% ownership in Unbuzzd Wellness Inc., along with royalty rights equal to 7% of product sales until cumulative royalty payments reach $250 million, after which the royalty rate falls to 3% in perpetuity. The structure provides Quantum BioPharma with potential long-term exposure to the commercialization success of the product while maintaining rights related to pharmaceutical and medical-use formulations. 

The company has also emphasized the commercial leadership supporting the unbuzzd platform. Quantum BioPharma notes that the initiative involves executives and advisors with backgrounds at major consumer beverage companies, including Co-Chair Gerry David, previously the CEO of Celsius Holdings, and John Duffy, previously with The Coca-Cola Company. Another advisor connected to the product is Kevin Harrington, one of the original investors featured on “Shark Tank.”

As neurological disease prevalence continues rising worldwide, biotechnology companies pursuing differentiated therapeutic approaches and adjacent wellness technologies may attract increasing industry attention. Quantum BioPharma’s strategy combines clinical-stage neurodegenerative drug development targeting helping patients get back the mobility and control of their bodies they have lost due to MS with broader commercial initiatives targeting alcohol misuse and metabolic wellness making people sober faster. 

For more information, visit www.QuantumBioPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to QNTM are available in the company’s newsroom at https://ibn.fm/QNTM 

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

• SPARC AI’s establishment of a wholly owned Ukrainian subsidiary marks a shift from distributor-led expansion to direct execution in one of the most operationally demanding drone warfare environments in the world.
• Ukraine’s battlefield conditions, including persistent GPS jamming and rapid drone deployment cycles, create a real-world proving ground few defense technology companies can replicate.
• With manufacturer partnerships, operator relationships, and a permanent in-country team, SPARC AI is building both distribution infrastructure and field validation simultaneously.

Modern warfare is increasingly being shaped by software rather than hardware alone. As Ukraine’s drone campaign expands deeper into Russian territory and the Pentagon evaluates Ukrainian combat drones and electronic warfare systems for potential procurement, defense priorities are shifting toward technologies that can preserve navigation, targeting, and operational continuity when conventional systems fail. In contested environments, GPS denial is no longer a theoretical problem. It is an active battlefield constraint.

SPARC AI (CSE: SPAI) (OTCQB: SPAIF) is positioning itself around that exact challenge. Early in May, the company announced plans to establish a permanent operational presence in Ukraine through a wholly owned subsidiary intended to accelerate adoption of its Overwatch software platform across the country’s defense drone ecosystem. The move includes hiring a local country manager, business development personnel, and engineering support to facilitate software deployment, customer integration, and field operations.

For a company commercializing GPS-denied navigation software, Ukraine is not simply another market opportunity. It is arguably the most relevant operating environment available.

Why Ukraine Matters

Ukraine has become one of the most technologically demanding combat environments for autonomous systems anywhere in the world. Russian electronic warfare capabilities routinely disrupt GPS signals, forcing Ukrainian operators to adapt rapidly in real time. Drone warfare has evolved from tactical reconnaissance into a core element of battlefield strategy, with Ukrainian forces increasingly using low-cost FPV drones to disrupt logistics, target command infrastructure, and strike deeper into contested territory. A recent overnight strike on the heavily defended Moscow Oil Refinery, which was reportedly forced to temporarily halt operations, illustrated how far that reach has extended.

President Volodymyr Zelenskyy recently indicated that Ukraine had expanded its mid-range strike contracting at five times the pace of the prior year, underscoring how quickly drone-dependent operations are scaling.

This environment directly aligns with SPARC AI’s thesis. Overwatch is designed to enhance positioning accuracy by leveraging sensors already embedded within drone platforms, rather than requiring additional hardware modifications. That software-based model has potential commercial advantages, particularly in defense environments where deployment speed, cost efficiency, and scalability matter.

Just as importantly, each field deployment creates operational feedback that can improve the system’s machine learning performance over time.

Building Distribution from Both Directions

The Ukrainian subsidiary is not an isolated development. It represents the next stage of a broader commercialization strategy that has been taking shape over recent months.

In April, SPARC AI announced its second Ukrainian drone manufacturer partnership, adding to an earlier agreement in the region. The company also entered an arrangement with a member of the Ukrainian National Guard involved in drone pilot training, creating another channel into active operator networks.

Outside Ukraine, SPARC AI has also announced a U.S.-based partnership with Rate Manufacturing to integrate Overwatch into its Model-F multi-mission drone systems. The company has also established a distribution relationship with Precision Technic Defense Group covering European markets, an Indian drone manufacturer partnership, and an arrangement with a group working closely with the United Arab Emirates Ministry of Defense.

The strategy appears deliberate.

By embedding Overwatch directly into manufacturer platforms while also building relationships with operators using those systems in the field, SPARC AI is pursuing both supply-side integration and real-world validation at the same time. Manufacturers create deployment scale. Operators generate performance data and practical credibility.

That combination could prove important if the company seeks broader defense adoption.

The Broader Defense Shift

The Pentagon’s growing interest in Ukrainian battlefield technologies suggests that software-defined defense systems are becoming a strategic priority.

According to recent reporting, the U.S. Department of Defense is seeking to evaluate Ukrainian drones and electronic warfare systems domestically, with particular interest in combat-tested technologies that solve modern battlefield problems. Secretary of the Army Dan Driscoll recently described Ukraine’s integrated drone operating network as a capability the U.S. military currently lacks. On May 12, 2026, the State Department and Ukrainian Ambassador Olha Stefanishyna negotiated a draft memorandum outlining a defense agreement that would allow Kyiv to export its combat-tested military technology to American manufacturers, a first step toward establishing joint drone manufacturing ventures.

That backdrop matters.

As electronic warfare threats expand and GPS spoofing becomes more common, the demand for alternative navigation and targeting solutions may extend beyond active conflict zones into broader military and commercial autonomy markets.

SPARC AI’s software-centric approach could fit that trend, particularly if Overwatch demonstrates repeatable performance across larger deployments.

Execution Still Matters

The commercial case remains early stage.

Defense technology companies often face long procurement cycles, pilot programs that never convert, and ongoing validation requirements across multiple operating environments. SPARC AI is no exception.

The company still needs to demonstrate that Overwatch can perform consistently at scale and that its growing network of partnerships can translate into recurring commercial contracts.

Still, the company’s recent actions suggest a transition from concept to execution.

Rather than discussing theoretical market opportunities, SPARC AI is placing personnel inside the environment most likely to stress-test its technology.

In a defense market increasingly shaped by software resilience rather than hardware alone, that may prove to be the more important signal.

For more information, visit the company’s website at https://sparcai.co.

NOTE TO INVESTORS: The latest news and updates relating to SPAIF are available in the company’s newsroom at https://ibn.fm/SPAIF

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

• Private investment in the space sector reached record levels in 2025, with momentum expected to continue as defense spending, sovereign satellite investment, and launch infrastructure demand accelerate.
• Planet Ventures is pursuing a public-market investment model designed to give shareholders access to private aerospace and space technology companies that have historically been the domain of venture and institutional capital.
• The company’s growing portfolio spans launch systems, orbital infrastructure, satellite-adjacent technologies, and aerospace innovation across multiple segments of the expanding space economy.

The global space economy is entering another expansion phase, but unlike earlier cycles driven primarily by speculative launch enthusiasm, the current wave is being shaped by infrastructure, defense priorities, and strategic capital deployment. According to Reuters, private investment in the sector climbed 48% in 2025 to a record $12.4 billion, with continued growth expected in 2026 as governments increase defense-linked spending and private investors expand exposure to launch capacity, satellite systems, and AI-integrated aerospace technologies.

That backdrop is reshaping how investors think about the sector. Direct access to private aerospace companies remains limited for most public market participants, particularly as many of the most closely watched opportunities remain venture-backed or institutionally financed. Planet Ventures (CSE: PXI) (OTC: PNXPF) has built its strategy around that structural gap.

A Public Vehicle Built Around Private Space Exposure

Planet Ventures is structured as an investment issuer focused specifically on identifying and investing in innovative companies operating across the space and aerospace sectors. Rather than functioning as a single-product aerospace operator, the company is pursuing a portfolio-based investment model intended to provide shareholders with indirect exposure to emerging private companies positioned across different layers of the space economy.

That distinction matters. The commercial space sector remains capital intensive, technologically complex, and often inaccessible to traditional retail investors. Many private aerospace companies raise capital through venture networks, strategic investors, or institutional channels long before broader public market participation becomes possible. Planet’s strategy is built around creating access through public ownership.

According to the company, its investment focus spans both upstream and downstream segments of the space economy, including launch infrastructure, spacecraft manufacturing, satellite communications, Earth observation, navigation systems, and adjacent aerospace technologies.

Building Exposure Across Multiple Space Themes

The broader sector opportunity extends well beyond rockets. As commercial activity expands, the addressable opportunity increasingly includes the infrastructure required to support persistent space operations, including manufacturing, orbital logistics, communications systems, and mission-enabling technologies.

Planet Ventures’ portfolio reflects that broader view. The company’s website identifies investments that include exposure to Antaris Inc., Mantis Space, Galactic Resource Utilization Space Inc., General Astronautics, and Lux Aeterna. This diversified structure gives the company exposure across multiple emerging themes rather than concentrating risk in a single operating asset.

That portfolio-style approach aligns more closely with venture investing than traditional single-company public equity exposure. For investors seeking participation in the commercial space buildout, diversification may matter given the long timelines, technical hurdles, and capital requirements that often define aerospace development.

The Macro Environment Has Shifted

Space investment is no longer being framed purely as a speculative frontier capital. Governments increasingly view orbital infrastructure, satellite capability, and aerospace manufacturing as strategic assets tied to national security and economic competitiveness, and that shift has accelerated capital flows into the sector.

Reuters recently reported that U.S. investment accounted for approximately 60% of global private space funding in 2025, driven heavily by launch services and defense-related initiatives. Analysts expect further momentum from sovereign satellite investment, missile defense priorities, and broader commercialization of space-enabled infrastructure.

Private market participation has followed that trend. For companies like Planet Ventures, that creates an environment where access itself may become a differentiator. Rather than attempting to build operating infrastructure directly, the company is positioning around ownership exposure to businesses pursuing that work.

A Different Kind of Space Market Story

The company’s model offers a distinct public-market approach to a sector where access has historically been constrained. The commercial space economy is increasingly attracting serious capital, but much of the most compelling activity continues happening behind private financing rounds rather than on public exchanges. Planet Ventures is attempting to bridge that gap.

For investors who view the next phase of aerospace growth as being driven by infrastructure, strategic investment, and private innovation rather than short-term speculation, that model presents a differentiated way to think about exposure.

For more information, visit www.PlanetVenturesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to PNXPF are available in the company’s newsroom at https://ibn.fm/PNXPF

Disclaimer

Investor Brand Network (“We” or “Us”) are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Planet Ventures Inc. will make aggregate payments of $100,000  to us to provide marketing services for a term of 1 year. This article is informational only and is solely for use by prospective investors in determining whether to seek additional information. This does not constitute an offer to sell or a solicitation of an offer to buy any securities. Our stock profiles are intended to highlight certain companies for your further investigation; they are not stock recommendations or constitute an offer or sale of the referenced securities. The securities issued by the companies we profile should be considered high risk; if you do invest despite these warnings, you may lose your entire investment. Please do your own research before investing, including reading the companies’ SEDAR+ and SEC filings, press releases, and risk disclosures. 

Forward-Looking Statements

This document contains forward-looking statements within the meaning of applicable securities legislation. Such statements include, without limitation, statements regarding: Planet Ventures’ investment strategy and objectives; anticipated developments in the commercial space industry, including the growth of orbital energy and space robotics markets; the projected growth of the global space economy; Planet Ventures’ expectations regarding the strategic importance of its investments in Mantis Space and General Astronautics; the anticipated role of orbital energy technologies and robotic servicing systems in future in-orbit operations; and the potential for these technologies to become foundational to the next generation of commercial space activity.

Forward-looking statements are not guarantees of future performance. Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements contained in this document are made as of the date hereof and Planet Ventures undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws.

Risk Factors

Investing in Planet Ventures and its portfolio companies involves a high degree of risk. The following is a summary of key risk factors. This is not an exhaustive list, and additional risks may exist that are not currently known:

• Early-Stage Investment Risk. Portfolio companies have limited operating histories and are pre-revenue. Investments are speculative and may result in a total loss of capital.
• Technology Risk. The orbital energy and lunar habitation technologies underlying the Company’s investments are unproven at commercial scale and may not be successfully developed or deployed.
• Regulatory Risk. Space sector operations require licenses and approvals from domestic and international regulatory bodies. Failure to obtain or maintain these could materially delay or prevent operations.
• Market Risk. Commercial demand for in-space power systems and lunar services has not been established at scale. Projected market growth may not be realized within anticipated timeframes.
• Liquidity Risk. Investments in private, early-stage companies are illiquid. There is no guarantee of a market for these securities or the ability to exit on favorable terms.
• Capital Risk. Portfolio companies may require additional funding that may not be available, or may be available only on dilutive or restrictive terms.
• Macroeconomic and Geopolitical Risk. Adverse macroeconomic conditions or geopolitical developments could disrupt the Company’s investment strategy or the operations of portfolio companies.
• Key Personnel Risk. The Company’s performance depends in part on retaining key personnel and advisors. Loss of key individuals could adversely affect the Company’s operations and investment activities.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

• Lahontan has mobilized a second drill rig to Santa Fe following approval of its exploration Plan of Operations, opening access to more than 700 new drill locations across its Nevada land package. 
• Recent cyanide extractable analyses from the 2025 reverse-circulation program at West Santa Fe averaged 81% gold and 60% silver recoveries, supporting the project’s heap-leach processing thesis. 
• The Santa Fe Mine combines past production history, a defined NI 43-101 resource base, and a development pathway management has publicly outlined. 

Junior mining capital has narrowed considerably. Exploration stories that once attracted financing on geological thesis alone are now being asked to demonstrate something more tangible: permitting visibility, infrastructure context, metallurgical results, and a realistic pathway toward production. In that environment, companies attracting attention are increasingly those positioned closer to production rather than still defining a target. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) fits that profile more cleanly than many of its peers.

A Past Producer, not a Concept

The company’s flagship 28.3 km² Santa Fe Mine project sits in Nevada’s Walker Lane and is not a conceptual exploration target. The property previously produced 359,202 ounces of gold and 702,067 ounces of silver between 1988 and 1995 through open pit mining and heap-leach processing. That production history provides operational precedent, infrastructure context, and geological validation that purely greenfield programs cannot offer.

The current NI 43-101 compliant resource estimate includes an indicated resource of 1,539,000 gold-equivalent ounces and an inferred resource of 411,000 gold-equivalent ounces, giving the company a defined asset base to advance rather than build from scratch. Management has publicly framed 2027 as a target window for resumption of mining operations at Santa Fe, anchoring the development narrative to a stated timeline rather than open-ended exploration.

Permitting Progress Opens a Much Larger Footprint

One of the more meaningful recent catalysts arrived in March, when Lahontan mobilized a track-mounted reverse-circulation drill rig to Santa Fe following approval of its exploration Plan of Operations. The new rig augments a diamond rig already on site and provides access to more than 700 new permitted drill locations across the project.

This materially expands the project’s exploration flexibility. Most prior drilling had focused on resource definition and expansion tied to development planning. The added capacity now allows the company to test areas of the property that were under-explored or overlooked by previous operators, broadening the work program across what management describes as a district-scale land package.

For junior developers, this category of progress is often underappreciated. Capital-intensive projects routinely stall when regulatory pathways remain unclear and having that framework approved removes a layer of execution risk that many earlier-stage peers continue to carry.

Metallurgy Strengthens the Economic Narrative

Resource ounces alone do not establish a viable mine. Processing economics frequently determines whether ounces in the ground translate into recoverable, economic metal, making metallurgical performance a critical variable in any production case.

That context makes Lahontan’s April announcement particularly relevant. The company reported extractable cyanide recoveries averaging 81% for gold and 60% for silver from 158 pulp samples taken from its 2025 reverse-circulation drilling program at West Santa Fe. Cyanide extractable gold results ranged from 41% to greater than 100%, while silver results ranged from 19% to 91%.

The results compared favorably with historical recovery assumptions previously associated with the project and support continued metallurgical optimization work. For Nevada gold projects, heap-leach compatibility remains one of the more important inputs into capital intensity and operating costs. Santa Fe also carries historical heap-leach operating precedent, making the metallurgical case less theoretical than at an early-stage asset.

A Better Match for Today’s Capital Environment

The broader junior mining environment remains challenging. Exploration companies continue competing for capital in a market increasingly demanding clearer pathways to execution and visible near-term catalysts. Discovery stories still attract attention, but investor focus has shifted toward issuers that can demonstrate infrastructure, defined resources, permitting status, and operational de-risking working in combination.

Lahontan’s positioning reflects that shift. The combination of a past-producing asset, an updated resource estimate, expanded drilling capacity, validated metallurgy, and a stated production objective creates a profile that reads differently from peers still building the foundational geological case.

Execution risk has not been removed. Additional drilling, an updated Preliminary Economic Assessment, engineering work, and financing milestones will ultimately determine the pace at which Santa Fe advances.

What has changed is the composition of the story. In a sector where credibility is increasingly tied to what comes after exploration, Lahontan is presenting a development narrative that more closely aligns with what the market has shown a willingness to fund.

For more information, visit the company’s website at www.LahontanGoldCorp.com. 

NOTE TO INVESTORS: The latest news and updates relating to LGCXF are available in the company’s newsroom at ibn.fm/LGCXF

• The rapid rise of AI is already reshaping electricity consumption worldwide.
• Frontieras’ proprietary FASForm technology processes coal into multiple high-value outputs rather than using it solely for combustion.
• The company also focuses on infrastructure compatibility.

Artificial intelligence (“AI”) is transforming the way the world uses energy. From massive data centers to advanced manufacturing systems, the technologies powering the AI boom require enormous amounts of reliable electricity, putting growing pressure on existing energy infrastructure. Frontieras North America is positioning itself within that shift through its proprietary FASForm(TM) platform, which converts coal into fuels, hydrogen and industrial products, changing one of the world’s most abundant resources into a multi-output industrial energy system.

The rapid rise of AI is already reshaping electricity consumption worldwide. According to the International Energy Agency, global electricity demand from data centers is expected to more than double by 2030, driven largely by artificial intelligence applications and large-scale computing systems. The agency estimates that electricity demand from data centers could reach more than 945 terawatt-hours by the end of the decade, a level greater than the current annual electricity consumption of many industrialized nations.

That growth is placing increasing pressure on power grids and energy infrastructure. AI systems require massive computing capacity, and those systems consume large amounts of electricity around the clock. Training advanced AI models, operating hyperscale data centers and supporting cloud computing networks all depend on a reliable energy supply. Unlike some sectors where energy demand fluctuates throughout the day, large AI infrastructure systems often require stable baseload power operating continuously.

Major technology companies have already begun investing heavily in energy infrastructure to support future AI demand. According to Reuters, several large data center projects under development in the United States are expected to require power consumption levels comparable to those of small cities. Utilities and grid operators have also warned that rising electricity demand tied to artificial intelligence, electrification and industrial expansion is creating new strain on existing generation systems and transmission networks.

Frontieras North America is advancing a different approach to energy and industrial production that addresses these concerns. The company’s proprietary FASForm technology processes coal into multiple high-value outputs rather than using it solely for combustion. The system thermally fractionates coal into liquid fuels, hydrogen and purified industrial carbon products through a continuous-feed process that captures and repurposes byproducts.

The company positions coal not as a declining resource but as an underutilized one. Coal remains one of the most abundant energy resources in the world, with global proved recoverable coal reserves totaling approximately 1.16 trillion short tons. The Frontieras model is built around increasing the value extracted from that resource by converting it into multiple industrial and energy products simultaneously.

FASForm produces diesel, naphtha, jet fuel, hydrogen, FASCarbon(TM) (technical carbon) and ammonium sulfate fertilizer from a single feedstock stream, according to company materials. These products serve established global industries tied to transportation, manufacturing, aviation, refining, agriculture and industrial production; the markets connected to the company’s product portfolio exceed a combined estimated value of $2.1 trillion.

In addition, hydrogen production is becoming particularly important as industrial energy demand rises. Hydrogen is widely used in refining, industrial processing and chemicals manufacturing, and Frontieras generates hydrogen directly as part of its fractionation process. The company’s first planned commercial-scale facility in Mason County, West Virginia, is designed to generate more than 20 million standard cubic feet of hydrogen per day while processing approximately 7,500 tons of coal daily.

Frontieras also focuses on infrastructure compatibility. Rather than replacing existing industrial systems, the company’s FASGEN(TM) platform upgrades coal infrastructure by intercepting coal before combustion and routing it through the FASForm process to produce multiple energy and material streams. This approach allows existing coal infrastructure to serve broader industrial markets while leveraging established transportation and supply-chain networks.

In addition, the company owns a patent for its exclusive Witherspoon method, named after company cofounder and CTO Joseph Witherspoon. This process works with FASForm to produce large volumes of fertilizer and other usable industrial products from otherwise would-be waste material, such as sulfur and other compounds. These outputs are integrated directly into the economics of the system, alongside fuels, hydrogen and industrial carbon.

As AI continues driving global energy demand higher, industries and governments alike are searching for scalable systems capable of supporting long-term industrial growth. Frontieras North America is positioning its FASForm platform within that landscape. The company’s unique approach transforms coal into a diversified industrial resource tied to fuels, hydrogen and large-scale manufacturing markets. In an era increasingly defined by energy-intensive technologies, the company’s model focuses on extracting greater value from one of the world’s largest and most established energy resources.

For more information about Frontieras, visit the company’s website at www.Frontieras.com.

NOTE TO INVESTORS: The latest news and updates relating to Frontieras are available in the company’s newsroom at https://ibn.fm/Frontieras

• Oncotelic Therapeutics maintained the fair value of its 45% GMP Biotechnology JV stake at approximately $388 million in Q1 2026 despite broader biotech market volatility
• The valuation was supported by an independent ASC 820 Level 3 assessment using discounted cash flow analysis and market comparables
• These developments reinforce Oncotelic’s partnership-driven model, designed to advance a multi-billion-dollar oncology pipeline while limiting traditional biotech cash burn pressures

Oncotelic Therapeutics (OTCQB: OTLC) continues to distinguish itself within a biotechnology sector often characterized by aggressive capital raises and persistent cash burn. In its recently filed first-quarter 2026 financial results, the company maintained the fair value of its 45% ownership stake in GMP Biotechnology Limited at approximately $388 million, signaling relative stability during a period in which many emerging biotech valuations have faced significant downward pressure (ibn.fm/zeoOT).

“We believe the first quarter of 2026 continues to provide validation for the strategic value of our diversified biotechnology platform,” said Dr. Vuong Trieu, CEO of Oncotelic. “During the quarter, we continued advancing our oncology and AI-enabled development initiatives while maintaining the previously established fair value assessment of our GMP Bio joint venture interest as disclosed in our U.S. Securities and Exchange Commission (“SEC”) filing.”

The valuation was derived from an independent ASC 820 Level 3 assessment that incorporated discounted cash flow methodologies alongside market comparable analysis. Notably, the company reported that no valuation adjustment was necessary during the quarter despite broader volatility affecting small-cap biotechnology and healthcare equities.

Unlike many early-stage biotech companies that rely heavily on recurring equity dilution to fund operations, Oncotelic has pursued a more partnership-driven strategy. Its GMP Biotechnology joint venture structure allows the company to leverage shared development infrastructure, in-house GMP manufacturing capabilities, and collaborative financing mechanisms designed to reduce direct operating cash demands. As a result, this model has helped the company maintain a comparatively modest cash burn profile relative to many traditional clinical-stage biotech peers pursuing fully internal development programs.

Investor interest also continues to center on the company’s broader pipeline potential. Previous third-party analysis from Frost & Sullivan estimated the combined valuation potential of Oncotelic’s pipeline assets at more than $1.7 billion, highlighting the scale of opportunity across its oncology and rare disease programs (ibn.fm/wBSmO).

As demonstrated by investor interest in platform-driven biotechnology companies such as Northwest Biotherapeutics (OTC: NWBO), CytoDyn (OTC: DYDY), Sangamo Therapeutics (OTC: SGMO), and most recently Insilico Medicine (OTC: ISLMF)—which completed the largest biotechnology IPO in Hong Kong in 2025 and achieved a market capitalization exceeding US$2 billion following its public debut—investors continue to assign significant value to companies built around differentiated therapeutic and technology platforms rather than a single product opportunity.”

At the center of the company’s portfolio is OT-101 (Trabedersen), a first-in-class antisense RNA therapeutic targeting TGF-beta2, a pathway associated with tumor immune evasion and disease progression. The therapy has been evaluated across multiple cancer indications, including glioblastoma, pancreatic cancer, colorectal cancer, melanoma, and diffuse intrinsic pontine glioma (“DIPG”), a rare and aggressive pediatric brain cancer for which the company has received rare pediatric disease designation. OT-101 is currently advancing through later-stage development programs and combination studies involving checkpoint inhibitors and IL-2 immunotherapy approaches.

Beyond OT-101, Oncotelic maintains a diversified pipeline that includes CA4P, a vascular disrupting agent being explored for melanoma and solid tumors, OXi4503 for leukemia indications, and AL-101, an intranasal apomorphine candidate targeting Parkinson’s disease, erectile dysfunction, and female sexual dysfunction through the FDA’s 505(b)(2) regulatory pathway. The company has also expanded into nanoparticle delivery technologies and AI-enabled drug development initiatives through its proprietary PDAOAI platform, which is designed to support regulatory workflows, data analysis, and therapeutic discovery efforts.

The company’s strategy reflects growing industry interest in combining artificial intelligence with precision medicine and targeted therapeutics. Management believes this integrated approach could help accelerate development timelines while improving capital efficiency across multiple programs. Broader industry research continues to suggest that AI-driven drug discovery platforms may play an increasingly important role in reducing development costs and streamlining therapeutic identification in future biotechnology pipelines.

At the same time, the company’s regulatory filings provide important context for investors evaluating the story. Because the GMP Biotechnology stake is categorized as a Level 3 asset under ASC 820 accounting standards, the valuation relies heavily on internal assumptions and financial modeling rather than active public market pricing. In addition, the company continues to manage debt obligations and has included going-concern disclosures that are common among development-stage biotech firms. These factors remain important considerations when assessing the company’s overall risk profile and long-term investment potential.

For more information, visit the company’s website at www.Oncotelic.com.

NOTE TO INVESTORS: The latest news and updates relating to OTLC are available in the company’s newsroom at ibn.fm/OTLC

• MindWave Innovations is building institutional-grade digital asset treasury infrastructure designed to help corporations manage Bitcoin holdings through custody, reporting, and yield-generation capabilities
• The company’s broader ecosystem spans AdTech, InsurTech and ClimateTech, creating a multi-vertical blockchain-enabled platform
• Following its reverse merger with Apimeds Pharmaceuticals US, MindWave is now positioned as a publicly traded digital asset infrastructure company on the NYSE American

In corporate finance, treasury management has traditionally centered on capital preservation, liquidity, internal controls, and predictable yield. That framework is being tested as a growing number of companies leaning into Bitcoin not as a speculative trade, but as a strategic treasury asset. The first question was whether digital assets belonged on the balance sheet at all. The next question is more practical: how should institutions manage them?

MindWave Innovations Inc. (NYSE American: APUS) is positioning itself around that challenge through a blockchain-enabled financial infrastructure ecosystem designed for institutional digital asset management. The company is developing institutional-grade treasury infrastructure that combines custody, yield-generation capabilities, compliance-oriented reporting, and tokenized ecosystem functionality within a broader AI- and blockchain-powered platform architecture.

Rather than focusing solely on passive Bitcoin exposure, MindWave is building an interoperable ecosystem intended to support enterprise treasury operations, tokenized incentives, decentralized infrastructure participation, and cross-platform digital asset utility.

Moving Beyond Passive Bitcoin Ownership

Corporate Bitcoin adoption has evolved quickly. Early public-company strategies focused largely on acquisition and long-term holding, but treasury management extends well beyond ownership. Public companies must also consider custody, board oversight, reporting transparency, risk management, and capital efficiency.

That creates a different set of infrastructure requirements than those typically associated with early crypto markets. Much of the first generation of digital asset infrastructure was built around retail participation, speculative trading, or decentralized finance experimentation. Institutional treasury teams operate under a different set of expectations.

MindWave’s stated approach is aimed at that gap. Its platform is designed around segregated custody structures, insured protection mechanisms, and reporting frameworks intended to align digital asset management with traditional treasury disciplines.

Building a Treasury Infrastructure Stack

MindWave’s treasury strategy extends beyond custody alone.

The platform architecture is designed to function as an integrated treasury operating environment where custody, staking participation, yield optimization, reporting, and tokenized asset functionality operate within a connected ecosystem rather than through fragmented third-party solutions.

According to the company’s white paper, the ecosystem leverages validator-node participation, AI-driven analytics, blockchain interoperability frameworks, and tokenized service layers intended to create multiple forms of platform engagement and recurring utility.

A Multi-Vertical Ecosystem

Beyond treasury infrastructure, MindWave is building a broader digital ecosystem designed to connect multiple application areas.

Its AdTech vertical, Wave+, is structured to convert digital engagement into tokenized incentives through sustainability-linked participation models. The InsurTech framework combines blockchain-based mechanisms with traditional underwriting concepts intended to address digital asset protection. Its ClimateTech initiative, Aquae Impact, focuses on tokenized ecological and environmental asset verification.

Connecting these verticals is the company’s native $NILA token, which is intended to serve as the ecosystem’s economic layer for staking, interoperability, and service activation.

While the treasury business is likely the most immediately relevant to capital markets, the broader ecosystem reflects an effort to position the company at the intersection of digital assets, artificial intelligence, and blockchain-enabled enterprise infrastructure.

Public Market Positioning

MindWave’s public-market emergence followed its 2026 reverse merger with Apimeds Pharmaceuticals US, Inc. A recently announced settlement resolved outstanding disputes tied to that transaction, clearing the path for the completion of merger-related matters and the company’s previously disclosed up to $100 million PIPE financing.

The settlement also separated the legacy Apitox biopharmaceutical program into Lōkahi Therapeutics, allowing the company’s strategic focus to shift toward digital asset treasury infrastructure and technology development.

For digital asset infrastructure providers, public-company status may carry strategic relevance. Institutional counterparties often place value on transparency, and reporting discipline that align with their own internal controls.

The institutional Bitcoin treasury category remains early, but the direction is becoming clearer. As more companies consider digital assets as treasury holdings, the conversation may increasingly shift from ownership itself to the infrastructure required to manage those assets responsibly at scale. MindWave Innovations is building around that emerging opportunity.

For more information, visit the company’s website at www.MindWaveDAO.com.

NOTE TO INVESTORS: The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.

• The latest drilling at hole MM26-7 intersected approximately 39 metres of the targeted Meade Peak phosphatic interval, pending assay confirmation.
• The company is advancing a broader exploration program focused on the Upper Phosphatic Zone within the Meade Peak Member.
• Nevada Organic Phosphate is targeting the expanding North American market for direct application organic phosphate fertilizer.
• Domestic phosphate supply is becoming critical amid global fertilizer supply-chain uncertainty and geopolitical concentration risk.
• The Murdock Mountain Property benefits from access to highway, rail, and trucking infrastructure, serving national agricultural markets.

Nevada Organic Phosphate (CSE: NOP) (OTCQB: NOPFF), a B.C.-based leader in organic sedimentary phosphate exploration, recently reported encouraging preliminary observations from its ongoing 2026 drilling campaign at the Murdock Mountain Property in Elko County, Nevada. The company said drill hole MM26-7 intersected an apparent 39 metres of the targeted Meade Peak stratigraphic interval. The drill hole was completed to a depth of 152 metres and positioned roughly 100 metres north and upslope from drill hole MM25-1 completed during the prior exploration season (https://ibn.fm/S9rmS).

According to the company, last year’s MM25-1 hole intersected approximately 38 metres of the same Meade Peak interval.

Management noted that the current exploration focus remains the Upper Phosphatic Zone, a 3.4 to 7.6 metre interval located within the broader Meade Peak Member. That geological framework was originally identified through earlier trench observations and historical academic work.

Laboratory assays will be required to confirm phosphate grades, thickness variations and the true dimensions of the mineralized intervals encountered during the current drilling program.

Nevada Organic Phosphate also confirmed that drill hole MM26-8 has now been completed approximately 100 metres north of last year’s MM25-3 hole. Additional geological observations and collar data are expected once logging work is finalized.

The latest drilling update arrives as phosphate markets continue attracting renewed strategic attention. Phosphorus remains an essential agricultural nutrient, with approximately 90% of global phosphorus consumption tied to fertilizer production. While Morocco controls the world’s largest phosphate reserves and China remains the dominant phosphate fertilizer producer and exporter, Western agricultural markets continue seeking greater supply diversification amid geopolitical and logistical uncertainty.

Those concerns have intensified following recent disruptions to global fertilizer trade routes linked to instability around the Strait of Hormuz, a corridor through which a substantial portion of the world’s fertilizer shipments normally pass.

Nevada Organic Phosphate is attempting to position the Murdock Mountain Property within that broader shift toward domestic and regionally secure fertilizer supply. Unlike conventional phosphate operations that typically involve extensive downstream chemical processing, the company is focused on organic sedimentary phosphate suitable for direct application agriculture. Management says the project is designed around raw rock phosphate intended for grinding, bagging and direct agricultural use rather than large-scale chemical conversion. 

That distinction places the company within the expanding organic and regenerative agriculture sector. The company does not have to compete with the conventional chemical agricultural input industry.

American farming practices have increasingly shifted toward reactive phosphate products and soil-focused nutrient management systems intended to work alongside natural soil biology. Nevada Organic Phosphate argues its material may align with those trends because it can be applied directly to agricultural land without conventional chemical processing.

The company estimates the Murdock Project currently hosts an Exploration Target Mineral Inventory, or ETMI, ranging between 10 million and 46 million tonnes grading between 3% and 15% P2O5. The estimate is based on an average thickness of 3.5 metres and a specific gravity of 2.61.

In addition to the main Murdock Mountain target zone, the company has identified three additional target areas that could extend the overall phosphate-bearing strike length to more than 30 kilometres.

Importantly, Nevada Organic Phosphate emphasises that further drilling, geological interpretation and assay work will be required before the scale and continuity of mineralization can be fully assessed.

Infrastructure access may also represent an important operational advantage. The Murdock Mountain Property is situated near major transportation corridors, including highway access connecting to Montello and Elko, Nevada, as well as nearby rail infrastructure capable of serving national agricultural markets.

Nevada Organic Phosphate added that surveying work from the prior drilling campaign has now been completed by a licensed surveyor, with updated mapping expected in a future release. Additional 2026 drill collar surveys will also be completed as the exploration program advances. The company added that future technical disclosures, including assay results and detailed geological interpretations, will be reviewed by qualified independent geological professionals under applicable Canadian disclosure standards.

For more information, visit the company’s website at www.NevadaPhosphate.com.

NOTE TO INVESTORS: The latest news and updates relating to NOP are available in the company’s newsroom at https://ibn.fm/NOP